Results 41 to 50 of about 83,603 (244)

The Novel ACTC1 p.Gly50Ser Variant Is Associated With Arrhythmia and Secondary Features of HCM Without Hypertrophy

open access: yesAmerican Journal of Medical Genetics Part A, EarlyView.
ABSTRACT The key diagnostic criterion for hypertrophic cardiomyopathy is the presence of otherwise unexplained hypertrophy. Current definitions of HCM rely on specific thresholds to establish a diagnosis, while guideline directed risk stratification algorithms take its magnitude into consideration.
Thomas D. Gossios   +9 more
wiley   +1 more source

Spirometry in chronic obstructive pulmonary disease in Norwegian general practice

open access: yesBMC Family Practice, 2020
Background General practitioners (GPs) in Norway increasingly use spirometry diagnostically as well as in follow up of patients with respiratory complaints, but little is known about their skills and knowledge in this area.
Mette C. Tollånes   +3 more
doaj   +1 more source

Targeted Anti‐IL‐1 Immunomodulatory Therapy in Pediatric Onset PPP1R13L‐Related Arrhythmogenic Cardiomyopathy

open access: yesAmerican Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Autosomal recessive loss‐of‐function variants in PPP1R13L cause an ultra‐rare cardiocutaneous syndrome characterized by rapidly progressive arrhythmogenic cardiomyopathy (ACM). PPP1R13L encodes iASPP, which has two potentially overlapping mechanisms driving ACM as both a regulator of NFκB‐mediated inflammation and a binding partner within the ...
Aaron Renberg   +9 more
wiley   +1 more source

Barnes Hospital Bulletin [PDF]

open access: yes, 1990
https://digitalcommons.wustl.edu/bjc_barnes_bulletin/1287/thumbnail ...

core   +4 more sources

Early clinical pharmacology evaluation of the novel anti‐inflammatory macrolide, glasmacinal (EP395): tolerability, pharmacokinetics and drug interactions

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aims This work assessed the pharmacokinetics (PK), safety and tolerability of glasmacinal (EP395, an oral anti‐inflammatory macrolide with negligible antimicrobial activity in development for COPD treatment) in two healthy participant trials: ‘first‐in‐human’ (FIH) and ‘drug–drug‐interaction’ (DDI).
Dave Singh   +5 more
wiley   +1 more source

Holter ECG

open access: yesActa Médica Colombiana, 2021
Holter ...
openaire   +2 more sources

Trajectories of quality of life, anxiety and depressive symptomatology, and health‐related work productivity after first seizure events

open access: yesEpilepsia Open, EarlyView.
Abstract Objective First seizure events are common and may exert an immediate and profound impact on people's lives. Less understood are their long‐term consequences. This prospective, longitudinal study aimed to measure and compare psychosocial and health‐related work productivity trajectories following first seizure events of various etiologies ...
Emma Foster   +13 more
wiley   +1 more source

Catheter ablation of atrial fibrillation : radiofrequency catheter ablation for redo procedures after cryoablation [PDF]

open access: yes, 2013
Aim: To evaluate the effectiveness of two different strategies using radiofrequency catheter ablation for redo procedures after cryoablation of atrial fibrillation. Methods: Thirty patients (paroxysmal atrial fibrillation: 22 patients, persistent atrial
Gramley, Felix, Kettering, Klaus
core   +1 more source

Eletrocardiografia Dinâmica-Holter

open access: yesJournal of Cardiac Arrhythmias, 1993
Os parâmetros da variabilidade da frequência cardíaca (VRR) têm se demonstrado de grande valor prognóstico para eventos arrítmicos graves e para a morte súbita cardíaca. Está comprovada a importância da atividade vagai como protetora contra a induçao de arritmias ventriculares.
Fábio Sandoli de BRITO   +1 more
openaire   +33 more sources

Home - About - Disclaimer - Privacy